Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Unknown 1Completed 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Gynecologic 2Breast 2Genitourinary 1

Conditions

Carcinoma, Hepatocellular 3Pancreatic Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 228Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Hydroxymethylglutaryl-CoA Reductase Inhibitors × Gastrointestinal × Clear all
NCT04245644 2024-03-12

CAOS

IRCCS San Raffaele

Unknown
800 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03219372 2021-01-22

Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence

Cedars-Sinai Medical Center

Phase 2 Terminated
1 enrolled 5 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT03490461 2018-04-06

Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation

Yonsei University

Completed
350 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02819869 2017-04-19

The Combination Effect of Statin Plus Metformin on Relapse-free

Taipei Medical University WanFang Hospital

Phase 2 Terminated
3 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡